Literature DB >> 20228951

Corporate Power and Social Policy: The Political Economy of the Transnational Tobacco Companies.

Chris Holden1, Kelley Lee.   

Abstract

Drawing on published tobacco document research and related sources, this article applies Farnsworth and Holden's conceptual framework for the analysis of corporate power and corporate involvement in social policy (2006) to the transnational tobacco companies (TTCs). An assessment is made of TTCs' structural power, the impact upon their structural position of tobacco control (TC) policies, and their use of agency power. The analysis suggests that, as a result of the growth of TC policies from the 1950s onwards, TTCs have had to rely on political agency to pursue their interests and attempt to reassert their structural position. The collapse of the Eastern bloc and the liberalisation of East Asian economies presented new structural opportunities for TTCs in the 1980s and 1990s, but the development of globally coordinated TC policies facilitated by the World Health Organisation's Framework Convention on Tobacco Control has the potential to constrain these.

Entities:  

Year:  2009        PMID: 20228951      PMCID: PMC2836532          DOI: 10.1177/1468018109343638

Source DB:  PubMed          Journal:  Glob Soc Policy        ISSN: 1468-0181


  24 in total

1.  Curbing the epidemic: governments and the economics of tobacco control. The World Bank.

Authors: 
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Tobacco industry documents: treasure trove or quagmire?

Authors:  R E Malone; E D Balbach
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 3.  Implications of the tobacco industry documents for public health and policy.

Authors:  Lisa Bero
Journal:  Annu Rev Public Health       Date:  2001-11-06       Impact factor: 21.981

4.  Industrial epidemics, public health advocacy and the alcohol industry: lessons from other fields.

Authors:  René I Jahiel; Thomas F Babor
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

5.  Tobacco lobby political influence on US state legislatures in the 1990s.

Authors:  M S Givel; S A Glantz
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

6.  "The law was actually drafted by us but the Government is to be congratulated on its wise actions": British American Tobacco and public policy in Kenya.

Authors:  Preeti Patel; Jeff Collin; Anna B Gilmore
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

7.  Tobacco Institute lobbying at the state and local levels of government in the 1990s.

Authors:  C P Morley; K M Cummings; A Hyland; G A Giovino; J K Horan
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

8.  Gaining access to Vietnam's cigarette market: British American Tobacco's strategy to enter 'a huge market which will become enormous'.

Authors:  K Lee; H V Kinh; R Mackenzie; A B Gilmore; N T Minh; J Collin
Journal:  Glob Public Health       Date:  2008

Review 9.  The global tobacco disease pandemic: nature, causes, and cures.

Authors:  K E Warner; J Mackay
Journal:  Glob Public Health       Date:  2006

10.  Tobacco industry issues management organizations: creating a global corporate network to undermine public health.

Authors:  Patricia A McDaniel; Gina Intinarelli; Ruth E Malone
Journal:  Global Health       Date:  2008-01-17       Impact factor: 4.185

View more
  21 in total

1.  Commentary: Moving towards policy coherence in trade and health.

Authors:  Helen Walls; Phillip Baker; Richard Smith
Journal:  J Public Health Policy       Date:  2015-08-06       Impact factor: 2.222

2.  Rhetoric and the law, or the law of rhetoric: How countries oppose novel tobacco control measures at the World Trade Organization.

Authors:  Raphael Lencucha; Jeffrey Drope; Ronald Labonte
Journal:  Soc Sci Med       Date:  2016-07-25       Impact factor: 4.634

3.  Influencing trade policy in a multi-level system - Understanding corporate political activity in the context of global value chains and regime complexity.

Authors:  Louise Curran; Jappe Eckhardt
Journal:  Bus Polit       Date:  2017-09-25

4.  Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea.

Authors:  Sungkyu Lee; Chris Holden; Kelley Lee
Journal:  Glob Public Health       Date:  2013-01-18

5.  A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement.

Authors:  Benjamin Hawkins; Chris Holden
Journal:  J Health Polit Policy Law       Date:  2016-06-02       Impact factor: 2.265

6.  'A preferred consultant and partner to the Royal Government, NGOs, and the community': British American Tobacco's access to policy-makers in Cambodia.

Authors:  Ross MacKenzie; Jeff Collin
Journal:  Glob Public Health       Date:  2016-04-15

7.  Globalization, first-foods systems transformations and corporate power: a synthesis of literature and data on the market and political practices of the transnational baby food industry.

Authors:  Phillip Baker; Katheryn Russ; Manho Kang; Thiago M Santos; Paulo A R Neves; Julie Smith; Gillian Kingston; Melissa Mialon; Mark Lawrence; Benjamin Wood; Rob Moodie; David Clark; Katherine Sievert; Monique Boatwright; David McCoy
Journal:  Global Health       Date:  2021-05-21       Impact factor: 4.185

8.  Cleavages and co-operation in the UK alcohol industry: a qualitative study.

Authors:  Chris Holden; Benjamin Hawkins; Jim McCambridge
Journal:  BMC Public Health       Date:  2012-06-26       Impact factor: 3.295

9.  'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market.

Authors:  Chris Holden; Kelley Lee
Journal:  Global Health       Date:  2011-05-19       Impact factor: 4.185

10.  Industry use of evidence to influence alcohol policy: a case study of submissions to the 2008 Scottish government consultation.

Authors:  Jim McCambridge; Ben Hawkins; Chris Holden
Journal:  PLoS Med       Date:  2013-04-23       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.